Search results
Showing 646 to 660 of 726 results for innovative
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.
NICE priority methodological research areas.
Our science policy and research programme team produces high-quality, impactful research.
NICE's past research and projects
Access free webinars and paid-for masterclasses.
We assess the value of digital health technologies that offer the greatest potential to improve health and wellbeing.
Resources to help with NHS access, system engagement and understanding the therapeutic landscape.
Thousands more breast cancer patients to benefit from new NHS treatment
NICE approves ribociclib combination therapy to help prevent cancer returning in early-stage disease.
Tools for building or evaluating an evidence base Our role in the Innovative Licensing and Access Pathway (ILAP) Early access to...
If you’re unsure where to start or your circumstances are unique, we encourage you to get in touch. We’ll work with you to unpick your challenges and find a solution that meets your needs.
The innovative hybrid closed loop (HCL) systems offer improved blood sugar control and can transform daily life for families managing this complex condition.
Jobs in digital at NICE. Come and join us!
NICE leads the way in approving breakthrough treatment for multiple myeloma
People in England will become the first in the world to receive belantamab mafodotin for this indication following our recommendation and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approval earlier this year.
Dr Sarah Byron discusses how NICE is transforming to ensure more digital health technologies are adopted by the NHS.
Cutting-edge robotic surgery gets green light as 11 systems are recommended
Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.